Medical Affairs (MA) at a large global pharmaceutical company required a structured framework to transition products into the late-lifecycle products portfolio. The organization needed a consistent and optimized approach through the development of an adaptable, modular framework to account for product diversity and situation.
Vynamic mapped the internal organization across functions and roles into a RACI with senior management buy-in. Then a draft Transition Framework was developed, followed by validation at several organizational levels and a beta test.
- An industry leading Transition Framework ready for trial with outstanding organizational feedback.
- A Utilization Guide and Tools Suite was also developed, communicated, and rolled-out with KPIs.